Latest news
CVS Health Expands GLP-1 Access With $29 Visits, Lilly Deal - Pharmacy TimesPharmacy Times · Fri, 07 Aug 2026 16:09:33 GMTCVS Health (CVS) Is Down 8.6% After Raising EPS Outlook And Expanding GLP-1 Offerings - Has The Bull Case Changed? - simplywall.stsimplywall.st · Fri, 07 Aug 2026 07:34:47 GMTInside CVS Health's GLP-1 Push and Earnings Beat - Pharmaceutical CommercePharmaceutical Commerce · Thu, 06 Aug 2026 15:16:55 GMTMedicare Made Weight-Loss Drugs $50 A Month—Now Amazon, CVS And Walmart Race To Fill Prescriptions - ForbesForbes · Thu, 06 Aug 2026 13:55:39 GMTCVS Health Raised Its Outlook, but the Stock Still Fell - Barron'sBarron's · Wed, 05 Aug 2026 20:41:00 GMTCVS revamps its GLP-1 program with $29 appointments for weight-loss drugs - The IndependentThe Independent · Wed, 05 Aug 2026 14:46:00 GMTCVS Health eases GLP-1 medication access via Eli Lilly partnership - Chain Store AgeChain Store Age · Wed, 05 Aug 2026 14:01:20 GMTCVS Health enhances weight management offerings to support patients on GLP-1s - Drug Store NewsDrug Store News · Wed, 05 Aug 2026 13:41:44 GMT